Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Gladys Ferrere et al.|Cell Research|2019Cited by 246
Qualitative evaluation of motives for acceptance or refusal of early palliative care in patients included in early-phase clinical trials in a French comprehensive cancer center: the PALPHA studyMathilde Lochmann, Véronique Christophe, Magali Girodet et al.|Supportive Care in Cancer|2024Cited by 1
Integrated palliative care with early clinical trial: what oncologists say and what patients understandMathilde Lochmann, Véronique Christophe, Magali Girodet et al.|Supportive Care in Cancer|2026Cited by 0